CONFERENCE COVERAGE SERIES
DIAN-TU Pharma Consortium NexGen Trial Meeting
Washington, D.C.
13 – 14 April 2015
As DIAN Plans Trial Number Two, the Goal Is to Go Big
A NexGen prevention trial in familial Alzheimer’s mutation carriers will shoot for flexible testing of high doses and drug combinations.